Skip to Content

P&G Making Progress, but Colgate Is More Attractive

P&G Making Progress, but Colgate Is More Attractive

Erin Lash: A year since its proxy battle with activist investor Nelson Peltz came to an end, P&G shares have trended higher, up at a mid-single-digit clip, outpacing the low-single-digit appreciation in the S&P 500 Index over the same horizon. However, we believe this reflects signs of progress after the prudent steps taken to steady its course over the last several years, as opposed to the oversight of one additional board member.

Although P&G has begun to deliver on its strategic agenda (with organic sales up 4% in the first quarter of fiscal 2019, in excess of the flat- to low-single-digit gains that have characterized the business of late), growth has yet to prove broad based. For one, beauty languished a few years back, but has since reversed course, stringing together mid- to high-single-digit top-line gains over the past six quarters, after parting ways with unprofitable products and launching fare centered on its core anti-aging messaging. We surmise its grooming business--which has posted low-single-digit declines on average since the fourth quarter of fiscal 2017--is also poised for more sustainable sales growth, although not to the same magnitude, as it implements a similar formula after succumbing to intense competition from lower-price upstarts.

In this vein, we'd suggest management's actions to recalibrate its pricing in the segment, invest in on-trend new products, launch its own subscription-based sales model, and drive trials by sending razors to 18-year-old U.S. males, mirror the wide range of endeavors P&G pursued as it worked to steady its footing in beauty.

However, we don't believe the path to sustainable top-line gains will prove linear. As such, we believe shares could retreat if sales falter in the near term, creating a more attractive entry point for shareholders. In the meantime, investors wanting to stock up on the household and personal care sector should look to wide-moat Colgate, in our view, which trades at around a 10% discount to our $70 fair value estimate.

More in Stocks

About the Author

Erin Lash

Consumer Sector Director
More from Author

Erin Lash, CFA, is director of consumer sector equity research for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. In addition to leading the sector team, Lash covers packaged food and household and personal care companies.

Before joining Morningstar in 2006, she spent four years as an investment analyst covering retail, transportation, and technology firms for State Farm Insurance.

Lash holds a bachelor’s degree in finance from Bradley University and a master’s degree in business administration, with concentrations in accounting and finance, from the University of Chicago Booth School of Business. She also holds the Chartered Financial Analyst® designation. She ranked second in the food and tobacco industry in The Wall Street Journal’s annual “Best on the Street” analysts survey in 2013, the last year the survey was conducted.

Sponsor Center